ACHE and Alzheimer disease: In moderate‐to‐severe AD (Feldman et al., 2001; Tariot et al., 2001) and severe AD (Fedldman et al., 2005; Winblad et al., 2006) AChE inhibitors are associated with modest improvements in cognition, function and clinical global impression.